Literature DB >> 20032973

FDA regulation of dietary supplements and requirements regarding adverse event reporting.

V H Frankos1, D A Street, R K O'Neill.   

Abstract

In 1994, the Dietary Supplement Health and Education Act (DSHEA) amended the Federal Food, Drug, and Cosmetic Act (FDC Act) to set up a distinct regulatory framework for what we now call dietary supplements. The DSHEA was passed with the intent of striking a balance between providing consumers access to safe dietary supplements to help maintain or improve their health and giving the US Food and Drug Administration (FDA) authority to regulate and take action against manufacturers of supplements or supplement ingredients that present safety problems, are presented with false or misleading claims, or are adulterated or misbranded. This article will present FDA's recent experience in collecting and evaluating dietary supplement adverse event data for the purpose of assuring the public that the dietary supplements they purchase are safe.

Mesh:

Year:  2009        PMID: 20032973     DOI: 10.1038/clpt.2009.263

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Using natural language processing methods to classify use status of dietary supplements in clinical notes.

Authors:  Yadan Fan; Rui Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2018-07-23       Impact factor: 2.796

2.  Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach.

Authors:  Emily J Johnson; Vanessa González-Peréz; Dan-Dan Tian; Yvonne S Lin; Jashvant D Unadkat; Allan E Rettie; Danny D Shen; Jeannine S McCune; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2018-05-07       Impact factor: 3.922

3.  Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal Medicines.

Authors:  Eric S J Harris; Shugeng Cao; Bruce A Littlefield; Jane A Craycroft; Robert Scholten; Ted Kaptchuk; Yanling Fu; Wenquan Wang; Yong Liu; Hubiao Chen; Zhongzhen Zhao; Jon Clardy; Alan D Woolf; David M Eisenberg
Journal:  Sci Total Environ       Date:  2011-08-06       Impact factor: 7.963

4.  Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog.

Authors:  Adrienne C Bautista; Caroline E Moore; Yanping Lin; Martha G Cline; Noemi Benitah; Birgit Puschner
Journal:  BMC Vet Res       Date:  2015-06-19       Impact factor: 2.741

5.  Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.

Authors:  Yefeng Wang; Divya R Gunashekar; Terrence J Adam; Rui Zhang
Journal:  Stud Health Technol Inform       Date:  2017

6.  Chondroitin Sulfate in USA Dietary Supplements in Comparison to Pharma Grade Products: Analytical Fingerprint and Potential Anti-Inflammatory Effect on Human Osteoartritic Chondrocytes and Synoviocytes.

Authors:  Antonietta Stellavato; Odile Francesca Restaino; Valentina Vassallo; Elisabetta Cassese; Rosario Finamore; Carlo Ruosi; Chiara Schiraldi
Journal:  Pharmaceutics       Date:  2021-05-17       Impact factor: 6.321

7.  Methods for estimating causal relationships of adverse events with dietary supplements.

Authors:  Kazuki Ide; Hiroshi Yamada; Mamoru Kitagawa; Yohei Kawasaki; Yuma Buno; Kumi Matsushita; Masayuki Kaji; Kazuko Fujimoto; Masako Waki; Mitsuyoshi Nakashima; Keizo Umegaki
Journal:  BMJ Open       Date:  2015-11-25       Impact factor: 2.692

8.  Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme.

Authors:  Sompon Wanwimolruk; Supaluk Prachayasittikul; Virapong Prachayasittikul; Bouchra Bernichi
Journal:  EXCLI J       Date:  2012-03-28       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.